Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Skip to main content

Advertisement

Springer Nature Link
Log in

Genetics of Gestational Diabetes Mellitus and Maternal Metabolism

  • Pathogenesis of Type 2 Diabetes and Insulin Resistance (RM Watanabe, Section Editor)
  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

Gestational diabetes mellitus (GDM) is defined as abnormal glucose tolerance with onset or first recognition during pregnancy. Women with a history of GDM are at long-term risk for developing type 2 diabetes (T2DM), raising the question to what extent GDM and T2DM share a common genetic architecture. Meta-analysis of candidate gene studies and genome-wide association analysis (GWAS) have identified a number of genes which are reproducibly associated with GDM, including TCF7L2, GCK, KCNJ11, KCNQ1, CDKAL1, IGF2BP2, MTNR1B, and IRS1. These genes are also associated with T2DM. Candidate gene and GWAS have also identified genes associated with maternal metabolic traits, most of which are also associated with metabolic traits in the general population. Two genes, BACE2 and HKDC1, are uniquely associated with maternal metabolic traits. These studies suggest that there are similarities and differences between the genetic architecture of GDM and T2DM and metabolic quantitative traits in pregnant and non-pregnant populations.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. Ashwal E, Hod M. Gestational diabetes mellitus: Where are we now? Clin Chim Acta 2015.

  2. Buchanan TA, Xiang A, Kjos SL, Watanabe R. What is gestational diabetes? Diabetes Care. 2007;30 Suppl 2:S105–11.

    Article  CAS  PubMed  Google Scholar 

  3. Buchanan TA, Xiang AH. Gestational diabetes mellitus. J Clin Invest. 2005;115:485–91.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  4. Buchanan TA, Xiang AH, Page KA. Gestational diabetes mellitus: risks and management during and after pregnancy. Nat Rev Endocrinol. 2012;8:639–49.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  5. Dabelea D, Snell-Bergeon JK, Hartsfield CL, Bischoff KJ, Hamman RF, McDuffie RS. Kaiser Permanente of Colorado GDMSP, increasing prevalence of gestational diabetes mellitus (GDM) over time and by birth cohort: Kaiser Permanente of Colorado GDM screening program. Diabetes Care. 2005;28:579–84.

    Article  PubMed  Google Scholar 

  6. Ferrara A, Kahn HS, Quesenberry CP, Riley C, Hedderson MM. An increase in the incidence of gestational diabetes mellitus: Northern California, 1991-2000. Obstet Gynecol. 2004;103:526–33.

    Article  PubMed  Google Scholar 

  7. International association of diabetes and pregnancy groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy. Diabetes Care 2010; 33:676-682

  8. Butte NF. Carbohydrate and lipid metabolism in pregnancy: normal compared with gestational diabetes mellitus. Am J Clin Nutr. 2000;71:1256S–61.

    CAS  PubMed  Google Scholar 

  9. Lain KY, Catalano PM. Metabolic changes in pregnancy. Clin Obstet Gynecol. 2007;50:938–48.

    Article  PubMed  Google Scholar 

  10. Hadden DR, McLaughlin C. Normal and abnormal maternal metabolism during pregnancy. Semin Fetal Neonatal Med. 2009;14:66–71.

    Article  PubMed  Google Scholar 

  11. Di Cianni G, Miccoli R, Volpe L, Lencioni C, Del Prato S. Intermediate metabolism in normal pregnancy and in gestational diabetes. Diabetes Metab Res Rev. 2003;19:259–70.

    Article  PubMed  Google Scholar 

  12. Desoye G, Hauguel-de Mouzon S. The human placenta in gestational diabetes mellitus. The insulin and cytokine network. Diabetes Care. 2007;30(2):S120–6.

    Article  CAS  PubMed  Google Scholar 

  13. Newbern D, Freemark M. Placental hormones and the control of maternal metabolism and fetal growth. Curr Opin Endocrinol Diabet Obes. 2011;18:409–16.

    Article  CAS  Google Scholar 

  14. Butler AE, Cao-Minh L, Galasso R, Rizza RA, Corradin A, Cobelli C, et al. Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy. Diabetologia. 2010;53:2167–76.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  15. Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25:1862–8.

    Article  PubMed  Google Scholar 

  16. Bellamy L, Casas JP, Hingorani AD, Williams D. Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis. Lancet. 2009;373:1773–9.

    Article  CAS  PubMed  Google Scholar 

  17. McLellan JA, Barrow BA, Levy JC, Hammersley MS, Hattersley AT, Gillmer MD, et al. Prevalence of diabetes mellitus and impaired glucose tolerance in parents of women with gestational diabetes. Diabetologia. 1995;38:693–8.

    Article  CAS  PubMed  Google Scholar 

  18. Robitaille J, Grant AM. The genetics of gestational diabetes mellitus: evidence for relationship with type 2 diabetes mellitus. Genet Med. 2008;10:240–50.

    Article  CAS  PubMed  Google Scholar 

  19. Watanabe RM, Black MH, Xiang AH, Allayee H, Lawrence JM, Buchanan TA. Genetics of gestational diabetes mellitus and type 2 diabetes. Diabetes Care. 2007;30 Suppl 2:S134–40.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  20. Morris AP, Voight BF, Teslovich TM, Ferreira T, Segre AV, Steinthorsdottir V, et al. Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes. Nat Genet. 2012;44:981–90.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  21. Basile KJ, Johnson ME, Xia Q, Grant SF. Genetic susceptibility to type 2 diabetes and obesity: follow-up of findings from genome-wide association studies. Int J Endocrinol. 2014;2014:769671.

    Article  PubMed Central  PubMed  Google Scholar 

  22. Mohlke KL, Boehnke M. Recent advances in understanding the genetic architecture of type 2 diabetes. Hum Mol Genet. 2015;24:R85–92.

    Article  CAS  PubMed  Google Scholar 

  23. Gibson G. Rare and common variants: twenty arguments. Nat Rev Genet. 2011;13:135–45.

    Article  PubMed Central  Google Scholar 

  24. Lowe, Jr., William L., Reddy TE. Genomic approaches for understanding the genetics of complex disease. Genome Res. 2015;25:1432–41.

  25. Fu W, O’Connor TD, Akey JM. Genetic architecture of quantitative traits and complex diseases. Curr Opin Genet Dev. 2013;23:678–83.

    Article  CAS  PubMed  Google Scholar 

  26. Surakka I, Horikoshi M, Magi R, Sarin AP, Mahajan A, Lagou V, et al. The impact of low-frequency and rare variants on lipid levels. Nat Genet. 2015;47:589–97.

    Article  CAS  PubMed  Google Scholar 

  27. Mao H, Li Q, Gao S. Meta-analysis of the relationship between common type 2 diabetes risk gene variants with gestational diabetes mellitus. PLoS One. 2012;7, e45882.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  28. Zhang C, Bao W, Rong Y, Yang H, Bowers K, Yeung E, et al. Genetic variants and the risk of gestational diabetes mellitus: a systematic review. Hum Reprod Update. 2013;19:376–90. Extensive meta-analysis of candidate gene studies which identifies a number of genetic variants associated with GDM.

    Article  PubMed Central  PubMed  Google Scholar 

  29. Mulder H, Nagorny CL, Lyssenko V, Groop L. Melatonin receptors in pancreatic islets: good morning to a novel type 2 diabetes gene. Diabetologia. 2009;52:1240–9.

    Article  CAS  PubMed  Google Scholar 

  30. Peschke E, Muhlbauer E. New evidence for a role of melatonin in glucose regulation. Best Pract Res Clin Endocrinol Metab. 2010;24:829–41.

    Article  CAS  PubMed  Google Scholar 

  31. Stancakova A, Kuulasmaa T, Paananen J, Jackson AU, Bonnycastle LL, Collins FS, et al. Association of 18 confirmed susceptibility loci for type 2 diabetes with indices of insulin release, proinsulin conversion, and insulin sensitivity in 5,327 nondiabetic Finnish men. Diabetes. 2009;58:2129–36.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  32. Groenewoud MJ, Dekker JM, Fritsche A, Reiling E, Nijpels G, Heine RJ, et al. Variants of CDKAL1 and IGF2BP2 affect first-phase insulin secretion during hyperglycaemic clamps. Diabetologia. 2008;51:1659–63.

    Article  CAS  PubMed  Google Scholar 

  33. Irwin DM, Tan H. Evolution of glucose utilization: glucokinase and glucokinase regulator protein. Mol Phylogenet Evol. 2014;70:195–203.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  34. Ullrich S, Su J, Ranta F, Wittekindt OH, Ris F, Rosler M, et al. Effects of I(Ks) channel inhibitors in insulin-secreting INS-1 cells. Pflugers Arch. 2005;451:428–36.

    Article  CAS  PubMed  Google Scholar 

  35. Dimas AS, Lagou V, Barker A, Knowles JW, Magi R, Hivert MF, Benazzo A, Rybin D, Jackson AU, Stringham HM, Song C, Fischer-Rosinsky A, Boesgaard TW, Grarup N, Abbasi FA, Assimes TL, Hao K, Yang X, Lecoeur C, Barroso I, Bonnycastle LL, Bottcher Y, Bumpstead S, Chines PS, Erdos MR, Graessler J, Kovacs P, Morken MA, Narisu N, Payne F, Stancakova A, Swift AJ, Tonjes A, Bornstein SR, Cauchi S, Froguel P, Meyre D, Schwarz PE, Haring HU, Smith U, Boehnke M, Bergman RN, Collins FS, Mohlke KL, Tuomilehto J, Quertemous T, Lind L, Hansen T, Pedersen O, Walker M, Pfeiffer AF, Spranger J, Stumvoll M, Meigs JB, Wareham NJ, Kuusisto J, Laakso M, Langenberg C, Dupuis J, Watanabe RM, Florez JC, Ingelsson E, McCarthy MI, Prokopenko I, on behalf of the Mi. Impact of type 2 diabetes susceptibility variants on quantitative glycemic traits reveals mechanistic heterogeneity. Diabetes 2014;63:2158–71.

  36. Kurokawa N, Young EH, Oka Y, Satoh H, Wareham NJ, Sandhu MS, et al. The ADRB3 Trp64Arg variant and BMI: a meta-analysis of 44 833 individuals. Int J Obes (Lond). 2008;32:1240–9.

    Article  CAS  Google Scholar 

  37. Lefterova MI, Haakonsson AK, Lazar MA, Mandrup S. PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol Metab. 2014;25:293–302.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  38. Huopio H, Cederberg H, Vangipurapu J, Hakkarainen H, Paakkonen M, Kuulasmaa T, et al. Association of risk variants for type 2 diabetes and hyperglycemia with gestational diabetes. Eur J Endocrinol. 2013;169:291–7.

    Article  CAS  PubMed  Google Scholar 

  39. Stuebe AM, Wise A, Nguyen T, Herring A, North KE, Siega-Riz AM. Maternal genotype and gestational diabetes. Am J Perinatol. 2014;31:69–76.

    PubMed  Google Scholar 

  40. Huerta-Chagoya A, Vazquez-Cardenas P, Moreno-Macias H, Tapia-Maruri L, Rodriguez-Guillen R, Lopez-Vite E, et al. Genetic determinants for gestational diabetes mellitus and related metabolic traits in Mexican women. PLoS One. 2015;10, e0126408.

    Article  PubMed Central  PubMed  Google Scholar 

  41. Li Q, Chen M, Zhang R, Jiang F, Wang J, Zhou J, et al. KCNJ11 E23K variant is associated with the therapeutic effect of sulphonylureas in Chinese type 2 diabetic patients. Clin Exp Pharmacol Physiol. 2014;41:748–54.

    Article  CAS  PubMed  Google Scholar 

  42. Maruthur NM, Gribble MO, Bennett WL, Bolen S, Wilson LM, Balakrishnan P, et al. The pharmacogenetics of type 2 diabetes: a systematic review. Diabetes Care. 2014;37:876–86.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  43. Balsells M, Garcia-Patterson A, Sola I, Roque M, Gich I, Corcoy R. Glibenclamide, metformin, and insulin for the treatment of gestational diabetes: a systematic review and meta-analysis. BMJ. 2015;350:h102.

    Article  PubMed Central  PubMed  Google Scholar 

  44. Manolio TA. Genomewide association studies and assessment of the risk of disease. N Engl J Med. 2010;363:166–76.

    Article  CAS  PubMed  Google Scholar 

  45. Panoutsopoulou K, Tachmazidou I, Zeggini E. In search of low-frequency and rare variants affecting complex traits. Hum Mol Genet. 2013;22:R16–21.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Kwak SH, Kim SH, Cho YM, Go MJ, Cho YS, Choi SH, et al. A genome-wide association study of gestational diabetes mellitus in Korean women. Diabetes. 2012;61:531–41. The first and only GWAS performed to identify genetic variants associated with GDM.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  47. Scott RA, Lagou V, Welch RP, Wheeler E, Montasser ME, Luan J, et al. Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways. Nat Genet. 2012;44:991–1005.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  48. Marullo L, El-Sayed Moustafa JS, Prokopenko I. Insights into the genetic susceptibility to type 2 diabetes from genome-wide association studies of glycaemic traits. Curr Diab Rep. 2014;14:551.

    Article  PubMed  Google Scholar 

  49. Mei J, Liao S, Liu Y, Tan Y, Wang H, Liang Y, et al. Association of variants in CDKN2A/2B and CDKAL1 genes with gestational insulin sensitivity and disposition in pregnant Han Chinese women. J Diabetes Investig. 2015;6:295–301.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  50. Liao S, Liu Y, Chen X, Tan Y, Mei J, Song W, Gan L, Wang H, Yin S, Dong X, Chi S, Deng S. The Impact of Genetic Variants for Different Physiological Characterization of Type 2 Diabetes Loci on Gestational Insulin Signaling in Nondiabetic Pregnant Chinese Women. Reprod Sci 2015.

  51. Dupuis J, Langenberg C, Prokopenko I, Saxena R, Soranzo N, Jackson AU, et al. New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk. Nat Genet. 2010;42:105–16.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  52. Freathy RM, Hayes MG, Urbanek M, Lowe LP, Lee H, Ackerman C, et al. Hyperglycemia and adverse pregnancy outcome (HAPO) study: common genetic variants in GCK and TCF7L2 are associated with fasting and postchallenge glucose levels in pregnancy and with the new consensus definition of gestational diabetes mellitus from the international association of diabetes and pregnancy study groups. Diabetes. 2010;59:2682–9.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Weedon MN, Clark VJ, Qian Y, Ben-Shlomo Y, Timpson N, Ebrahim S, et al. A common haplotype of the glucokinase gene alters fasting glucose and birth weight: association in six studies and population-genetics analyses. Am J Hum Genet. 2006;79:991–1001.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Lowe LP, Metzger BE, Lowe Jr WL, Dyer AR, McDade TW, McIntyre HD. Inflammatory mediators and glucose in pregnancy: results from a subset of the hyperglycemia and adverse pregnancy outcome (HAPO) study. J Clin Endocrinol Metab. 2010;95:5427–34.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Urbanek M, Hayes MG, Lee H, Freathy RM, Lowe LP, Ackerman C, et al. The role of inflammatory pathway genetic variation on maternal metabolic phenotypes during pregnancy. PLoS One. 2012;7, e32958.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  56. Guzman-Flores JM, Escalante M, Sanchez-Corona J, Garcia-Zapien AG, Cruz-Quevedo EG, Munoz-Valle JF, et al. Association analysis between -308G/A and -238G/A TNF-alpha gene promoter polymorphisms and insulin resistance in Mexican women with gestational diabetes mellitus. J Investig Med. 2013;61:265–9.

    CAS  PubMed  Google Scholar 

  57. Hayes MG, Urbanek M, Hivert MF, Armstrong LL, Morrison J, Guo C, Lowe LP, Scheftner DA, Pluzhnikov A, Levine DM, McHugh CP, Ackerman CM, Bouchard L, Brisson D, Layden BT, Mirel D, Doheny KF, Leya MV, Lown-Hecht RN, Dyer AR, Metzger BE, Reddy TE, Cox NJ, Lowe WL, Jr. for the HSCRG. Identification of HKDC1 and BACE2 as Genes Influencing Glycemic Traits During Pregnancy Through Genome-Wide Association Studies. Diabetes 2013;62:3282–91. A recent GWAS which identified genetic variants associated with maternal metabolic traits during pregnancy.

  58. Esterhazy D, Stutzer I, Wang H, Rechsteiner MP, Beauchamp J, Dobeli H, et al. Bace2 is a beta cell-enriched protease that regulates pancreatic beta cell function and mass. Cell Metab. 2011;14:365–77.

    Article  CAS  PubMed  Google Scholar 

  59. Casas S, Casini P, Piquer S, Altirriba J, Soty M, Cadavez L, et al. BACE2 plays a role in the insulin receptor trafficking in pancreatic ss-cells. Am J Physiol Endocrinol Metab. 2010;299:E1087–95.

    Article  CAS  PubMed  Google Scholar 

  60. Guo C, Ludvik AE, Arlotto ME, Hayes MG, Armstrong LL, Scholtens DM, et al. Coordinated regulatory variation associated with gestational hyperglycaemia regulates expression of the novel hexokinase HKDC1. Nat Commun. 2015;6:6069. A follow-up study to a recent GWAS which further characterizes the association of genetic variants in HKDC1 with maternal glucose levels.

  61. Lowe Jr WL, Karban J. Genetics, genomics and metabolomics: new insights into maternal metabolism during pregnancy. Diabet Med. 2014;31:254–62.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  62. Petry CJ, Ong KK, Dunger DB. Does the fetal genotype affect maternal physiology during pregnancy? Trends Mol Med. 2007;13:414–21.

    Article  CAS  PubMed  Google Scholar 

  63. Petry CJ, Seear RV, Wingate DL, Manico L, Acerini CL, Ong KK, et al. Associations between paternally transmitted fetal IGF2 variants and maternal circulating glucose concentrations in pregnancy. Diabetes. 2011;60:3090–6.

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This work was funded by NIH DK097534.

Author information

Authors and Affiliations

  1. Division of Endocrinology, Metabolism, and Molecular Medicine and Department of Medicine, Northwestern University Feinberg School of Medicine, Rubloff Building 420 E. Superior St., 12th Floor, Chicago, IL, 60611, USA

    William L. Lowe Jr., Victoria Sandler & M. Geoffrey Hayes

  2. Department of Preventive Medicine, Northwestern University Feinberg School of Medicine, Suite 1400 680 N Lake Shore Drive, Chicago, IL, 60611, USA

    Denise M. Scholtens

  3. Division of Endocrinology, Metabolism and Molecular Medicine, Suite 530, 645 N Michigan Avenue, Chicago, IL, 60611, USA

    Victoria Sandler

  4. Division of Endocrinology, Metabolism and Molecular Medicine, Tarry Building, Room 15-759, 300 E Chicago Ave, Chicago, IL, 60611, USA

    M. Geoffrey Hayes

Authors
  1. William L. Lowe Jr.
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Denise M. Scholtens
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Victoria Sandler
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Geoffrey Hayes
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to William L. Lowe Jr..

Ethics declarations

Conflict of Interest

William L. Lowe, Jr., Denise M. Scholtens, Victoria Sandler, and M. Geoffrey Hayes declare that they have no conflict of interest.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Additional information

This article is part of the Topical Collection on Pathogenesis of Type 2 Diabetes and Insulin Resistance

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Lowe, W.L., Scholtens, D.M., Sandler, V. et al. Genetics of Gestational Diabetes Mellitus and Maternal Metabolism. Curr Diab Rep 16, 15 (2016). https://doi.org/10.1007/s11892-015-0709-z

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11892-015-0709-z

Keywords

Search

Navigation